B HALL STRATEGIES, LLC

Lobbying for TIBER CREEK GROUP ON BEHALF OF JAZZ PHARMACEUTICALS · Biopharmaceutical company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · Senate · $30,000.00 income · posted Jan 19, 2026

Lobbying activity 1

Medicare/Medicaid

General Medicare issues impacting Jazz Pharmaceuticals.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.